Search All UT System Experts

Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial

Adam L. Boxer, Irfan Qureshi, Michael Ahlijanian, Michael Grundman, Lawrence I. Golbe, Irene Litvan, Lawrence S. Honig, Paul Tuite, Nikolaus R. McFarland, Padraig O'Suilleabhain, Tao Xie, Giridhar S. Tirucherai, Clifford Bechtold, Yvette Bordelon, David S. Geldmacher, Murray Grossman, Stuart Isaacson, Theresa Zesiewicz, Tina Olsson, Kumar Kandadi MuralidharanDanielle L. Graham, John O'Gorman, Samantha Budd Haeberlein, Tien Dam

Research output: Contribution to journal › Article › peer-review

101 Scopus citations

Fingerprint

Dive into the research topics of 'Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial'. Together they form a unique fingerprint.

Medicine & Life Sciences